225 related articles for article (PubMed ID: 29267496)
1. T cell subsets and immunoglobulin G levels are associated with the infection status of systemic lupus erythematosus patients.
Wu L; Wang X; Chen F; Lv X; Sun W; Guo Y; Hou H; Ji H; Wei W; Gong L
Braz J Med Biol Res; 2017 Dec; 51(2):e4547. PubMed ID: 29267496
[TBL] [Abstract][Full Text] [Related]
2. Anti-CII antibody as a novel indicator to assess disease activity in systemic lupus erythematosus.
He C; Mao T; Feng Y; Song T; Qin C; Yan R; Feng P
Lupus; 2015 Nov; 24(13):1370-6. PubMed ID: 26048288
[TBL] [Abstract][Full Text] [Related]
3. Increased Tim-3 expression on peripheral T lymphocyte subsets and association with higher disease activity in systemic lupus erythematosus.
Song LJ; Wang X; Wang XP; Li D; Ding F; Liu HX; Yu X; Li XF; Shu Q
Diagn Pathol; 2015 Jun; 10():71. PubMed ID: 26076826
[TBL] [Abstract][Full Text] [Related]
4. Altered homeostasis of CD4(+) FoxP3(+) regulatory T-cell subpopulations in systemic lupus erythematosus.
Suen JL; Li HT; Jong YJ; Chiang BL; Yen JH
Immunology; 2009 Jun; 127(2):196-205. PubMed ID: 18800986
[TBL] [Abstract][Full Text] [Related]
5. Urine neopterin as a parameter of disease activity in patients with systemic lupus erythematosus: comparisons with serum sIL-2R and antibodies to dsDNA, erythrocyte sedimentation rate, and plasma C3, C4, and C3 degradation products.
Lim KL; Jones AC; Brown NS; Powell RJ
Ann Rheum Dis; 1993 Jun; 52(6):429-35. PubMed ID: 8323394
[TBL] [Abstract][Full Text] [Related]
6. [Serum free light chains for monitoring systemic lupus erythematosus activity].
Żychowska I; Suszek D; Dryglewska M; Nurzyńska D; Donica H; Majdan M
Wiad Lek; 2018; 71(1 pt 1):21-31. PubMed ID: 29558348
[TBL] [Abstract][Full Text] [Related]
7. Progressive reduction of serum complement levels: a risk factor for relapse in patients with hypocomplementemia in systemic lupus erythematosus.
Miyawaki Y; Sada K; Asano Y; Hayashi K; Yamamura Y; Hiramatsu S; Ohashi K; Morishita M; Watanabe H; Matsumoto Y; Kawabata T; Wada J
Lupus; 2018 Nov; 27(13):2093-2100. PubMed ID: 30309286
[TBL] [Abstract][Full Text] [Related]
8. Correlations between antinucleosome antibodies and anti-double-stranded DNA antibodies, C3, C4, and clinical activity in lupus patients.
Saisoong S; Eiam-Ong S; Hanvivatvong O
Clin Exp Rheumatol; 2006; 24(1):51-8. PubMed ID: 16539819
[TBL] [Abstract][Full Text] [Related]
9. Immunological and clinical differences between juvenile and adult onset of systemic lupus erythematosus.
Carreño L; López-Longo FJ; Monteagudo I; Rodríguez-Mahou M; Bascones M; González CM; Saint-Cyr C; Lapointe N
Lupus; 1999; 8(4):287-92. PubMed ID: 10413207
[TBL] [Abstract][Full Text] [Related]
10. CD69 to CD3 ratio of peripheral blood mononuclear cells as a marker to monitor systemic lupus erythematosus disease activity.
Su CC; Shau WY; Wang CR; Chuang CY; Chen CY
Lupus; 1997; 6(5):449-54. PubMed ID: 9229364
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies to box A of high mobility group box 1 in systemic lupus erythematosus.
Schaper F; de Leeuw K; Horst G; Maas F; Bootsma H; Heeringa P; Limburg PC; Westra J
Clin Exp Immunol; 2017 Jun; 188(3):412-419. PubMed ID: 28245520
[TBL] [Abstract][Full Text] [Related]
12. Association of Serum Ferritin Levels with Hematological Manifestations in Systemic Lupus Erythematosus Patients from Western India.
Pradhan V; Pandit P; Rajadhyaksha A; Patwardhan M; Surve P; Kamble P; Lecerf M; Bayry J; Kaveri S; Ghosh K; Nadkar MY
J Assoc Physicians India; 2016 May; 64(5):14-18. PubMed ID: 27735143
[TBL] [Abstract][Full Text] [Related]
13. Elevated interleukin-10 levels correlated with disease activity in systemic lupus erythematosus.
Park YB; Lee SK; Kim DS; Lee J; Lee CH; Song CH
Clin Exp Rheumatol; 1998; 16(3):283-8. PubMed ID: 9631750
[TBL] [Abstract][Full Text] [Related]
14. Association of Blood Concentrations of Complement Split Product iC3b and Serum C3 With Systemic Lupus Erythematosus Disease Activity.
Kim AHJ; Strand V; Sen DP; Fu Q; Mathis NL; Schmidt MJ; Bruchas RR; Staten NR; Olson PK; Stiening CM; Atkinson JP
Arthritis Rheumatol; 2019 Mar; 71(3):420-430. PubMed ID: 30294950
[TBL] [Abstract][Full Text] [Related]
15. Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome.
Inanç M; Donohoe S; Ravirajan CT; Radway-Bright EL; Mackie I; Machin S; Isenberg DA
Br J Rheumatol; 1998 Oct; 37(10):1089-94. PubMed ID: 9825748
[TBL] [Abstract][Full Text] [Related]
16. Dysregulated T Cell Activation and Aberrant Cytokine Expression Profile in Systemic Lupus Erythematosus.
Zhou H; Li B; Li J; Wu T; Jin X; Yuan R; Shi P; Zhou Y; Li L; Yu F
Mediators Inflamm; 2019; 2019():8450947. PubMed ID: 31007604
[TBL] [Abstract][Full Text] [Related]
17. The effect of methotrexate on improving serological abnormalities of patients with systemic lupus erythematosus.
Miyawaki S; Nishiyama S; Aita T; Yoshinaga Y
Mod Rheumatol; 2013 Jul; 23(4):659-66. PubMed ID: 23011357
[TBL] [Abstract][Full Text] [Related]
18. Altered peripheral lymphocyte subsets in untreated systemic lupus erythematosus patients with infections.
Lu Z; Li J; Ji J; Gu Z; Da Z
Braz J Med Biol Res; 2019; 52(4):e8131. PubMed ID: 30994732
[TBL] [Abstract][Full Text] [Related]
19. Correlation between clinical activity and serological markers in a wide cohort of patients with systemic lupus erythematosus: an eight-year prospective study.
Villegas-Zambrano N; Martínez-Taboada VM; Bolívar A; San Martín M; Alvarez L; Marín MJ; López-Hoyos M
Ann N Y Acad Sci; 2009 Sep; 1173():60-6. PubMed ID: 19758133
[TBL] [Abstract][Full Text] [Related]
20. Increased serum RANTES in patients with systemic lupus erythematosus.
Lu MM; Wang J; Pan HF; Chen GM; Li J; Cen H; Feng CC; Ye DQ
Rheumatol Int; 2012 May; 32(5):1231-3. PubMed ID: 21258798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
